Interaction of aqueous extract of Pleurotus pulmonarius (Fr.) Quel-Champ. with glyburide in alloxan induced diabetic mice

Evidence-based Complementary and Alternative Medicine

Volumn 5, Issue 2, 2008, Pages 159-164

  Badole, Sachin L ^a   Patel, Naimesh M ^a   Thakurdesai, Prasad A ^a   Bodhankar, Subhash L ^a  

^a BHARATI VIDYAPEETH DEEMED UNIVERSITY   (India)

Author keywords

Glyburide; Oral glucose tolerance test (OGTT); Pleurotus pulmonarius; Serum glucose

Indexed keywords

ALLOXAN; GLIBENCLAMIDE; GLUCOSE; PLANT EXTRACT; PLEUROTUS PULMONARIUS EXTRACT;

ALLOXAN DIABETES MELLITUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; BODY WEIGHT; CAPILLARY GLASS TUBE; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; DRUG SYNTHESIS; GLUCOSE BLOOD LEVEL; MALE; MEDICINAL PLANT; MORTALITY; MOUSE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PLEUROTUS PULMONARIUS; PRIORITY JOURNAL; PUNCTURE; STATISTICAL SIGNIFICANCE; TUBE;

EID: 44649126801     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1093/ecam/nem010     Document Type: Article

References (54)

1. Lindequist U, Niedermeyer TH, Julich WD. The pharmacological potential of mushrooms. Evid Based Complement Alternat Med 2005;2:285-99.
2. Wright T. Medicinal mushrooms. Nutraceuticals World. Ramsey, NJ: Roman Publishing, 2004, 26-9.
3. Tribe I, Tosco U. The World of Mushrooms. Vol viii. London: Orbis Publishing, 1973.
4. Miles PG, Chang S-T. Mushroom Biology: Concise Basics and Current Development. New York: World Scientific Publishing Company, 1997.
5. Khanna P, Garcha HS. Pleurotus mushroom- A source of food protein. Mushroom News Lett Tropics 1984;4:9-14.
6. Flegg PB, Maw GA. Mushroom and their possible contribution to world protein needs. Mushroom J 1976;48:396-405.
7. Bano Z. The nutritive value of mushrooms. Paper presented at: First Symposium on survey and cultivation of edible mushrooms of India, Regional Research Laboratory, Jammu, 1976; pp. 148-69.
8. Gray AM, Flatt PR. Insulin-releasing and insulin-like activity of Agaricus campestris (mushroom). J Endocrinol 1998;157:259-66.
9. Talpur N, Echard B, Dadgar A, Aggarwal S, Zhuang C, Bagchi D, et al. Effects of Maitake mushroom fractions on blood pressure of Zucker fatty rats. Res Commun Mol Pathol Pharmacol 2002;112:68-82.
10. Swanston-Flatt SK, Day C, Flatt PR, Gould BJ, Bailey CJ. Glycaemic effects of traditional European plant treatments for diabetes. Studies in normal and streptozotocin diabetic mice. Diabetes Res. 1989;10:69-73.
11. Coxeter PD, McLachlan AJ, Duke CC, Roufogalis BD. Herb-drug interactions: an evidence based approach. Curr Med Chem 2004;11:1513-25.
12. Bressler R. Herb-drug interactions: interactions between kava and prescription medications. Geriatrics 2005;60:24-25.
13. Poppenga RH. Herbal medicine: potential for intoxication and interactions with conventional drugs. Clin Tech Small Anim Pract 2002;17:6-18.
14. Fugh-Berman A, Ernst E. Herb-drug interactions: review and assessment of report reliability. Br J Clin Pharmacol 2001;52:587-95.
15. Woodward KN. The potential impact of the use of homeopathic and herbal remedies on monitoring the safety of prescription products. Hum Exp Toxicol 2005;24:219-33.
16. Izzo AA. Herb-drug interactions: an overview of the clinical evidence. Fundam Clin Pharmacol 2005;19:1-16.
17. Samane S, Noel J, Charrouf Z, Amarouch H, Haddad PS. Insulin-sensitizing and anti-proliferative effects of Argania spinosa seed extracts. Evid Based Complement Alternat Med 2006;3:317-27.
18. Zeng C, Liu Y, Wang Z, He D, Huang L, Yu P, et al. Activation of D3 dopamine receptor decreases angiotensin II type 1 receptor expression in rat renal proximal tubule cells. Circ Res 2006;99:494-500.
19. Kelly KM. Complementary and alternative medical therapies for children with cancer. Eur J Cancer 2004;40:2041-6.
20. Singh M, Varshneya C, Telang RS, Srivastava AK. Alteration of pharmacokinetics of oxytetracycline following oral administration of Piper longum in hens. J Vet Sci 2005;6:197-200.
21. Lin YC, Bioteau AB, Ferrari LR, Berde CB. The use of herbs and complementary and alternative medicine in pediatric preoperative patients. J Clin Anesth 2004;16:4-6.
22. Awang DV, Fugh-Berman A. Herbal interactions with cardiovascular drugs. J Cardiovasc Nurs 2002;16:64-70.
23. Badole SL, Shah SN, Patel NN, Thakurdesai PA, Bodhankar SL. Hypoglycemic activity of aqueous extract of Pleurotus pulmonarius (Fr.) Quel.-Champ in alloxan induced diabetic mice. Pharm Biol 2006;44:421-5.
24. Rao BK, Kesavulu MM, Giri R, Appa Rao C. Antidiabetic and hypolipidemic effects of Momordica cymbalaria Hook. fruit powder in alloxan-diabetic rats. J Ethnopharmacol 1999;67:103-9.
25. Abdel-Barry JA, Abdel-Hassan IA, Al-Hakiem MH. Hypoglycaemic and antihyperglycaemic effects of Trigonella foenum- graecum leaf in normal and alloxan induced diabetic rats. J Ethnopharmacol 1997;58:149-55.
26. Konno S, Tortorelis DG, Fullerton SA, Samadi AA, Hettiarachchi J, Tazaki H. A possible hypoglycaemic effect of maitake mushroom on type 2 diabetic patients. Diabet Med 2001;18:1010.
27. Hikino H, Takahashi M, Konno C, Ishimori A, Kawamura T, Namiki T. Effect of glycans of Saccharum officinarum on carbohydrate and lipid metabolism of rats. J Ethnopharmacol 1985;14:261-8.
28. Akhtar MS, Khan QM, Khaliq T. Effects of Portulaca oleracae (Kulfa) and Taraxacum officinale (Dhudhal) in normoglycaemic and alloxan-treated hyperglycaemic rabbits. J Pak Med Assoc 1985;35:207-10.
29. Takahasi M, Konno C, Hikino H. Isolation and hypoglycemic activity of Anemorans A, B, C and D, glycans of Anemarrhema asphodelcides rhizomes. Planta Med 1985;51:100-2.
30. Talpur NA, Echard BW, Fan AY, Jaffari O, Bagchi D, Preuss HG. Antihypertensive and metabolic effects of whole Maitake mushroom powder and its fractions in two rat strains. Mol Cell Biochem 2002;237:129-36.
31. Ewart RB, Kornfeld S, Kipnis DM. Effect of lectins on hormone release from isolated rat islets of langerhans. Diabetes. 1975;24:705-14.
32. Manohar V, Talpur NA, Echard BW, Lieberman S, Preuss HG. Effects of a water-soluble extract of maitake mushroom on circulating glucose/insulin concentrations in KK mice. Diabetes Obes Metab 2002;4:43-8.
33. Windholz M. The Merck index: an encyclopedia of chemicals, drugs and biologicals, 10th edn. New Jersey: Merck & Co., 1983.
34. Boyd AE. Sulfonylurea receptors, ion channels, and fruit flies. Diabetes 1988;37:847-50.
35. Groop LC. Sulfonylureas in NIDDM. Diabetes Care 1992;15:737-54.
36. Patane G, Piro S, Anello M, Rabuazzo AM, Vigneri R, Purrello F. Exposure to glibenclamide increases rat beta cells sensitivity to glucose. Br J Pharmacol 2000;129:887-92.
37. Elmi A, Idahl LA, Sehlin J. Relationships between the Na(+)/K(+) pump and ATP and ADP content in mouse pancreatic islets: effects of meglitinide and glibenclamide. Br J Pharmacol 2000;131:1700-06.
38. Ishikawa Y, Morimoto K, Hamasaki T. Flavoglaucin, a metabolite of Eurotium Chevalieri, its antioxidation and synergism with tocopherol. J Am Oil Chem Soc 1984;61:1864-8.
39. Mau JL, Lin HC, Song SF. Antioxidant properties of several specialty mushrooms. Food Res Int 2002;35:519-26.
40. Cheung PC, Lee MY. Fractionation and characterization of mushroom dietary fiber (nonstarch polysaccharides) as potential nutraceuticals from sclerotia of Pleurotus tuber-regium (Fries) singer. J Agric Food Chem 2000;48:3148-51.
41. Fu H, Shieh DE. Antioxidant and free radical scavenging activities of edible mushrooms. J Food Lipids 2002;9:35-46.
42. Yang JH, Lin HC, Mau JL. Antioxidant properties of several commercial mushrooms. Food Chem 2002;77:229-35.
43. Gumieniczek A, Hopkala H, Rolinski J, Bojarska-Junak A. Antioxidative and anti-inflammatory effects of repaglinide in plasma of diabetic animals. Pharmacol Res 2005;52:162-6.
44. Siemianowicz K, Gminski J, Telega A, Wojcik A, Posielezna B, Grabowska-Bochenek R, et al. Blood antioxidant parameters in patients with diabetic retinopathy. Int J Mol Med 2004;14:433-7.
45. Reddy SV, Tiwari AK, Kumar US, Rao RJ, Rao JM. Free radical scavenging, enzyme inhibitory constituents from antidiabetic Ayurvedic medicinal plant Hydnocarpus wightiana Blume. Phytother Res 2005;19:277-81.
46. Satheesh MA, Pari L. Antioxidant effect of Boerhavia diffusa L. in tissues of alloxan induced diabetic rats. Indian J Exp Biol 2004;42:989-92.
47. Sabu MC, Kuttan R. Antidiabetic activity of Aegle marmelos and its relationship with its antioxidant properties. Indian J Physiol Pharmacol 2004;48:81-8.
48. Ramkumar KM, Latha M, Venkateswaran S, Pari L, Ananthan R, Bai VN. Modulatory effect of Gymnema montanum leaf extract on brain antioxidant status and lipid peroxidation in diabetic rats. J Food Med 2004;7:366-71.
49. Vedavanam K, Srijayanta S, O'Reilly J, Raman A, Wiseman H. Antioxidant action and potential antidiabetic properties of an isoflavonoid-containing soyabean phytochemical extract (SPE). Phytother Res 1999;13:601-8.
50. Kumari K, Augusti KT. Antidiabetic and antioxidant effects of S-methyl cysteine sulfoxide isolated from onions (Allium cepa Linn) as compared to standard drugs in alloxan diabetic rats. Indian J Exp Biol 2002;40:1005-9.
51. Talpur N, Echard BW, Yasmin T, Bagchi D, Preuss HG. Effects of niacin-bound chromium, Maitake mushroom fraction SX and (-)-hydroxycitric acid on the metabolic syndrome in aged diabetic Zucker fatty rats. Mol Cell Biochem 2003;252:369-77.
52. Pan J, Chan EK, Cheta D, Schranz V, Charles MA. The effects of nicotinamide and glimepiride on diabetes prevention in BB rats. Life Sci 1995;57:1525-32.
53. Food and Agriculture Organization of the United Nations. Food Composition Table for Use in Africa. Vol ix. Bethesda, MD: US Department of Health, Education, and Welfare, Nutrition Program, and Food Consumption and Planning Branch, Food and Agriculture Organization of the United Nations, 1968.
54. Kusano S, Abe H, Tamura H. Isolation of antidiabetic components from white-skinned sweet potato (Ipomoea batatas L.). Biosci Biotechnol Biochem 2001;65:109-14.